• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Introduction to 2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid (CAS No. 1261990-58-2)

2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid, identified by the Chemical Abstracts Service Number (CAS No.) 1261990-58-2, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of benzoic acid derivatives, characterized by its complex aromatic structure, which includes both methoxy and methyl substituents. The presence of these functional groups imparts unique chemical properties, making it a valuable scaffold for the development of novel therapeutic agents.

The molecular structure of 2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid consists of a benzoic acid core substituted at the 3-position with a methoxycarbonyl group and at the 5-position with a methyl group. This arrangement creates a molecule with potential for diverse biological activities, including anti-inflammatory, antioxidant, and antimicrobial properties. The methoxycarbonyl group enhances the compound's solubility in polar solvents, while the methyl group contributes to steric hindrance, influencing its binding affinity to biological targets.

In recent years, there has been a growing interest in benzoic acid derivatives as pharmacophores due to their favorable pharmacokinetic profiles and minimal toxicity. Studies have demonstrated that modifications in the aromatic ring can significantly alter the biological activity of these compounds. For instance, the introduction of electron-withdrawing groups such as carboxylic acid and ester moieties can enhance binding interactions with enzymes and receptors. Similarly, alkyl substituents like methyl groups can influence metabolic stability and bioavailability.

One of the most compelling aspects of 2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid is its potential application in drug discovery. Researchers have explored its derivatives as intermediates in synthesizing more complex molecules with enhanced therapeutic efficacy. For example, modifications at the 3-position have been shown to improve binding affinity to cyclooxygenase-2 (COX-2), a key enzyme involved in inflammation. Additionally, structural analogs have demonstrated promising results in inhibiting lipoxygenase pathways, which are implicated in various inflammatory diseases.

The synthesis of 2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid involves multi-step organic reactions that require precise control over reaction conditions. Typically, it is synthesized through Friedel-Crafts acylation followed by esterification and selective methylation. Advanced techniques such as palladium-catalyzed cross-coupling reactions have also been employed to achieve higher yields and purities. These synthetic methodologies highlight the compound's importance as a building block in pharmaceutical chemistry.

Recent advancements in computational chemistry have further enhanced our understanding of the biological activity of 2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid. Molecular docking studies have revealed that this compound can interact with various protein targets, including kinases and transcription factors. These interactions are believed to modulate signaling pathways involved in cancer progression, neurodegenerative disorders, and metabolic diseases. Such insights have opened new avenues for developing targeted therapies based on this scaffold.

The pharmacological profile of 2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid has been extensively studied in vitro and in vivo. Preclinical trials have shown that certain derivatives exhibit significant anti-inflammatory effects without notable side effects. These findings are particularly promising for conditions such as rheumatoid arthritis and inflammatory bowel disease, where traditional treatments often suffer from limited efficacy or severe adverse reactions. Moreover, the compound's ability to cross the blood-brain barrier suggests potential applications in treating neuroinflammatory diseases.

From a regulatory perspective, 2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid (CAS No. 1261990-58-2) is subject to standard guidelines for chemical substances used in pharmaceutical research. Compliance with Good Manufacturing Practices (GMP) ensures that all synthetic intermediates meet stringent quality standards before being used in drug development programs. This adherence to regulatory protocols is crucial for ensuring safety and efficacy in clinical trials.

The future prospects of 2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid are vast, with ongoing research exploring its potential applications beyond traditional pharmaceuticals. For instance, its derivatives are being investigated as photoactive compounds for use in photodynamic therapy (PDT). Additionally, its structural features make it an attractive candidate for developing novel materials with applications in biotechnology and nanomedicine.

In conclusion,2-(3-methoxycarbonylphenyl)-5-methylbenzoic Acid represents a significant advancement in medicinal chemistry due to its versatile structure and promising biological activities. Its synthesis, pharmacological properties, and potential applications underscore its importance as a key intermediate in drug discovery efforts aimed at addressing various human diseases.

• 114772-34-8(Methyl 2-(p-Tolyl)benzoate)
• 16231-67-7([1,1'-Biphenyl]-2-carboxylicacid, 2'-formyl-, methyl ester)
• 171905-91-2([1,1'-Biphenyl]-2,3'-dicarboxylicacid, 3'-methyl ester)
• 36978-36-6([1,1'-Biphenyl]-2,3,3',4'-tetracarboxylicacid, 2,3,3',4'-tetramethyl ester)
• 205823-15-0([1,1'-Biphenyl]-2-carboxylicacid, 3'-formyl-, methyl ester)
• 32741-92-7([1,1'-Biphenyl]-2,4',5-tricarboxylicacid, 2,4',5-trimethyl ester)
• 158144-55-9([1,1'-Biphenyl]-2-carboxylicacid, 4'-(hydroxymethyl)-, methyl ester)
• 188943-06-8(Methyl 2'-Methyl-1,1'-biphenyl-2-carboxylate)
• 2941-80-2([1,1'-Biphenyl]-2,2'-dicarboxylicacid, 4,4'-dimethyl-, 2,2'-dimethyl ester)
• 144291-47-4(Methyl 2-(4-Formylphenyl)benzoate)